A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
Recruiting
N/A
Interventional Study
Ovarian Cancer
Ovarian Carcinoma
Stage II Ovary Cancer
Stage II Ovarian Cancer
Stage III Ovary Cancer
Stage III Ovarian Cancer
Stage IV Ovary Cancer
Stage IV Ovarian Cancer
Epithelial Ovarian Cancer
Fallopian Tube Cancer
Stage II Fallopian Tube Cancer
Stage III Fallopian Tube Cancer
Stage IV Fallopian Tube Cancer
Primary Peritoneal Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 35 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to see if propranolol and etodolac along with mind-body resilience training/MBRT and music therapy help participants who are experiencing physiological stress before, during, and after primary debulking surgery/PDS or IDS and also if it's better than the standard-of-care approach (no intervention for reducing stress).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Advanced (stage II-IV) epithelial ovarian, fallopian tube, or primary peritoneal carcinoma diagnosed on the basis of imaging, CA125, and clinical assessment
* Scheduled to undergo exploratory laparotomy and PDS or IDS
* Scheduled for surgery with at least 10 days of lead time,…
Contacts